Skip Maine state header navigation

Agencies | Online Services | Help

Skip First Level Navigation | Skip All Navigation

Home > Data & Research > Prescription Monitoring Program > IRC Resource Guide

Information & Resource Center ---- PMP Resource GuideResources for Physicians and Pharmacists

The Information and Resource Center at the Maine Office of Substance Abuse provides Maine citizens with information on drug abuse prevention and treatment. Our library catalog is on the web at http://maineosa.org/irc/ Contact us at 1-800-499-0027 or osa.ircosa@maine.gov for additional information on our resources and services.

VIDEOS

These videos may be borrowed from the Information and Resource Center.

  • Preventing Drug Diversion: A Program for Physicians
    (2003, 19 min., Fanlight Productions)
  • Preventing Drug Diversion: A Program for Pharmacists
    (2003, 18 min., Fanlight Productions)

These two training films will help physicians, pharmacists and others learn to prevent drug diversion and to comply with current legal requirements without unduly increasing costs or, more importantly, compromising patient care. Additional films on prescription drug addiction are also available.

  • Prescription Drugs: Killing More Than Pain (Broadcast 2/10/2005, 60 min., Multijurisdictional Counterdrug Task Force Training Program)

This hour-long broadcast looks at the problem of prescription drug abuse from all sides, including law enforcement, recovering addicts, treatment providers, doctors, and drugmakers.

BOOKS and REPORTS

Eban, K. (2005) Dangerous Doses : How Counterfeiters are Contaminating America's Drug Supply. Orlando : Harcourt.

Impact of Prescription Drug Diversion Control Systems on Medical Practice and Patient Care (NIDA Research Monograph 131) 1993. http://www.drugabuse.gov/pdf/monographs/download131.html

Legal Drugs, Illegal Purposes: The Escalating Abuse of Prescription Medications (pdf)

In August, 2003, a U.S. Senate Governmental Affairs Committee, chaired by Senator Susan Collins, convened in Bangor to address the growing problem of diverted prescription medication, a problem that has resulted in a sharp rise in overdose deaths in this state and nationally.   Read the testimony that was presented at this hearing.

Kramen, Pilar, (2004) Prescription Drug Diversion (Trends Alert-Critical Information for State Decision Makers) . Lexington, KY: Council of State Governments http://www.csg.org/pubs/Documents/TA0404DrugDiversion.pdf

Prescription Drugs: State Monitoring Programs Provide Useful Tool to Reduce Diversion. GAO-02-634 http://www.gao.gov/new.items/d02634.pdf

The President's Commission on Model State Drug Laws: v. 1. Economic remedies -- v. 2. Community mobilization -- v. 3. Crimes code -- v. 4. Treatment -- v. 5. Drug-free families, schools, and workplaces. http://www.natlalliance.org/modellaws.asp

Recommendations for Prescription Monitoring Programs http://www.fda.gov/ohrms/dockets/ac/03/briefing/3978B1_12_FDA-Tab11.pdf

ARTICLES

Check with your local health science librarian for availability.

Brushwood DB, Maximizing the value of electronic prescription monitoring programs. J Law Med Ethics. 2003 Spring; 31(1):41-54. http://www.painandthelaw.org/aslme_content/31-1/brushwood.pdf

Compton, WM, Volkow, ND, Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006 Jun; 83 sup.1: s4-7.

Gilson AM , A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control 1997-2002. J Pain Symptom Manage. 2004 Aug; 28 (2): 176-88.

Gilson AM, Joranson DE, Controlled substances and pain management: changes in knowledge and attitudes of state medical regulators. J Pain Symptom Manage. 2001 Mar; 21(3):227-37.

Hertz, JA, Knight, JR, Prescription drug misuse: a growing national problem. Adolesc Med Clin. 2006 Oct; 17(3): 751-69.

Hoffman L, Enders JL, & Pippins J, Reducing claims for prescription drugs with a high potential for abuse. Am J Health Syst Pharm. Feb 15, 2003; 60(4):371-4.

Joranson , DE , Carrow, GM & Ryan, KM, Pain management and prescription monitoring. J Pain Symptom Manage. 2002 Mar; 23(3):231-8.

Joranson , DE , Gilson AM, & Dahl JL, Pain management, controlled substances, and state medical board policy: a decade of change. J Pain Symptom Manage. 2002 Feb; 23(2):138-47.

Kroutil, LA, Van Brunt, DL et. al. Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend. Sept. 15, 2006; 84(2), 135-43.

Kuehn, BM. Scientists probe ways to curb opioid abuse without hindering pain treatment. JAMA. May 9, 2007; 297(18) : 1965-67.

McCabe, SE, Cranford, JA, et. al. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict Behav. 2007 Mar; 32(3): 562-75.

McCabe, SE, Teter, CJ, & Boyd, CJ, Medical use, illicit use and diversion of abusable prescription drugs. J Am Coll Health 2006 Mar-Apr; 54(5), 269-78.

Novak, S. Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med. 2004 Mar; 5 (1): 59-65.

Passik SD, Kirsh KL Assessing Aberrant Drug-taking Behaviors in the Patient with Chronic Pain. Curr Pain Headache Rep. 2004 Aug; 8(4):289-94.

Seeger VB, Vivian JC., Is it legitimate? Strategies for assessing questionable prescriptions. J Am Pharm Assoc ( Wash ). 2002 Sep-Oct; 42(5 Suppl 1):S58-9.

Simoni-Wastila L, Tompkins C., Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential. Subst Use Misuse. 2001 Jul-Aug; 36(9-10):1275-96.

Wilsey B, Fishman S, & Rose JS., Pain management in the ED. Am J Emerg Med. 2004 Jan; 22(1):51-7.

Woolf CJ, Hashmi M., Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids. Curr Opin Investig Drugs. 2004 Jan; 5(1):61-6.

Zacny J, Bigelow G, & Compton P., College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. Apr 1, 2003 ; 69(3):215-32.